サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1680372

医薬品の世界市場レポート 2025

Pharmaceutical Drugs Global Market Report 2025

出版日
ページ情報
英文 400 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
医薬品の世界市場レポート 2025
出版日: 2025年03月03日
発行: The Business Research Company
ページ情報: 英文 400 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.3%で、2,384億3,000万米ドルに成長します。予測期間の成長は、政府支援の増加、ヘルスケアへのアクセスの増加、投資の増加、高齢者人口の急増、医療費の増加、予防接種・ワクチン接種に対する意識の高まりに起因すると考えられます。予測期間における主な動向としては、医薬品開発におけるバイオマーカーの利用、次世代生物製剤の開発増加、個別化医療への注目の高まり、創薬のための人工知能（AI）への投資、呼吸器疾患治療のための併用薬物療法、医薬品研究開発を改善するためのウェアラブル企業との提携、医薬品製造における3Dプリンティング技術の利用、ドラッグデリバリーを改善・強化するためのマイクロニードルピル、MRNAを利用したワクチンの開発などが挙げられます。

座り仕事の増加、多忙なライフスタイル、消費者の嗜好の進化は、世界の疾病状況、特にがん、糖尿病、心血管疾患などの非感染性疾患の流行に影響を与えています。長時間労働、身体活動の低下、不健康な食習慣などの要因が、糖尿病などの慢性疾患に大きく寄与しています。世界保健機関（WHO）によると、非感染性疾患（NCDs）は年間4,100万人の死亡をもたらし、世界の死亡率の74％を占めています。この動向は、糖尿病などの病態に対処するための生物学的製剤に対する需要の高まりを裏付けています。これらの要因によって世界の患者数が拡大し、予測期間を通じて医薬品市場の成長が促進されると予想されます。

希少疾患の罹患率の増加は、将来の医薬品市場の成長を促進すると予想されます。希少疾患は、一般的な健康問題に比べて有病率が低く、少数の患者しか罹患しないことが特徴です。医薬品は、これらの疾患をよりよく管理し、潜在的な治療薬を特定し、深刻な副作用を伴う可能性のある不必要な治療を防ぎ、効果的な治療を促進する上で重要な役割を果たしています。例えば、2023年7月、英国政府機関であるGOV.UKは、現在7,000以上の希少疾病が知られており、研究の進歩に伴い新たな疾病も継続的に特定されていると報告しています。これらの疾患の約80％は遺伝的基盤が認められており、17人に1人が人生のある時点で希少疾患の影響を受けると推定されています。その結果、希少疾病の増加は医薬品市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の医薬品市場：成長率分析
  • 世界の医薬品市場の実績：規模と成長, 2019-2024
  • 世界の医薬品市場の予測：規模と成長, 2024-2029, 2034F
  • 世界医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の医薬品市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心臓血管薬
  • 皮膚科用医薬品
  • 胃腸薬
  • 泌尿器科用薬
  • 血液学薬
  • 抗感染薬
  • 代謝障害治療薬
  • 筋骨格障害治療薬
  • 中枢神経系薬
  • その他
  • 世界の医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他の流通チャネル
  • 世界の医薬品市場購入方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ブランド医薬品
  • ジェネリック医薬品
  • 世界の医薬品市場購入方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 市販薬（OTC）
  • 処方薬
  • 世界の医薬品市場、心血管薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 降圧剤
  • 抗凝固剤
  • コレステロール低下剤
  • 世界の医薬品市場皮膚科用医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 局所コルチコステロイド
  • ニキビ治療
  • 乾癬の治療
  • 世界の医薬品市場、胃腸薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 制酸剤
  • プロトンポンプ阻害剤
  • 下剤
  • 世界の医薬品市場、泌尿器科用医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ホルモン療法
  • 過活動膀胱に対する抗コリン薬
  • 勃起不全治療薬
  • 世界の医薬品市場、血液学薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗凝固剤
  • 血液量増加剤
  • 赤血球生成刺激剤
  • 世界の医薬品市場、抗感染症薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗生物質
  • 抗ウイルス薬
  • 抗真菌薬
  • 世界の医薬品市場代謝障害治療薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 糖尿病治療薬
  • 肥満治療薬
  • 甲状腺ホルモン補充療法
  • 世界の医薬品市場、筋骨格障害薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 非ステロイド性抗炎症薬（NSAID）
  • 疾患修飾性抗リウマチ薬（DMARD）
  • 筋弛緩剤
  • 世界の医薬品市場、中枢神経系薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗うつ薬
  • 抗精神病薬
  • 抗不安薬
  • 世界の医薬品市場、その他、タイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 化学療法
  • 標的療法
  • 免疫療法
  • 緑内障の治療
  • 抗アレルギー点眼薬
  • 網膜疾患治療薬
  • 喘息吸入器
  • COPD治療薬
  • 抗ヒスタミン薬
  • 感染症ワクチン
  • 慢性疾患の治療用栄養素
  • カルシウムサプリメント
  • 鉄サプリメント
  • マグネシウムサプリメント

第7章 地域別・国別分析

  • 世界の医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 バングラデシュ市場

第16章 タイ市場

第17章 ベトナム市場

第18章 マレーシア市場

第19章 シンガポール市場

第20章 フィリピン市場

第21章 香港市場

第22章 ニュージーランド市場

第23章 西欧市場

第24章 英国市場

第25章 ドイツ市場

第26章 フランス市場

第27章 イタリア市場

第28章 スペイン市場

第29章 スペイン市場

第30章 オーストリア市場

第31章 ベルギー市場

第32章 デンマーク市場

第33章 フィンランド市場

第34章 アイルランド市場

第35章 オランダ市場

第36章 ノルウェー市場

第37章 ポルトガル市場

第38章 スウェーデン市場

第39章 スイス市場

第40章 東欧市場

第41章 ロシア市場

第42章 チェコ共和国市場

第43章 ポーランド市場

第44章 ルーマニア市場

第45章 ウクライナ市場

第46章 北米市場

第47章 米国市場

第48章 カナダ市場

第50章 南米市場

第51章 ブラジル市場

第52章 チリ市場

第53章 アルゼンチン市場

第54章 コロンビア市場

第55章 ペルー市場

第56章 中東市場

第57章 サウジアラビア市場

第58章 イスラエル市場

第59章 イラン市場

第60章 トルコ市場

第61章 アラブ首長国連邦市場

第62章 アフリカ市場

第63章 エジプト市場

第64章 ナイジェリア市場

第65章 南アフリカ市場

第66章 競合情勢と企業プロファイル

  • 医薬品市場：競合情勢
  • 医薬品市場：企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第67章 その他の大手企業と革新的企業

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Bristol-Myers Squibb
  • AstraZeneca
  • GlaxosmithKline
  • Shanghai Pharmaceutical Drugs
  • Shanghai Fosun Pharmaceutical
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • China National Pharmaceutical Group Co., Ltd.（Sinopharm）
  • Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd
  • Hanmi Pharmaceutical
  • Cipla Limited

第68章 世界の市場競合ベンチマーキングとダッシュボード

第69章 主要な合併と買収

第70章 最近の市場動向

第71章 市場の潜在力が高い国、セグメント、戦略

  • 医薬品市場2029：新たな機会を提供する国
  • 医薬品市場2029：新たな機会を提供するセグメント
  • 医薬品市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第72章 付録

目次
Product Code: r25868

A pharmaceutical drug is a substance designed for the treatment, prevention, or alleviation of an illness, condition, or its symptoms. These substances can be administered through various methods, including oral consumption, skin patches, injections, or inhalation. Notable pharmaceuticals derived from natural sources encompass vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics.

The primary categories of pharmaceutical drugs cover a wide spectrum, including cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are specifically tailored to address medical conditions related to the heart or circulatory system, such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. These drugs can be administered through various routes, including oral and parenteral methods, and are categorized as branded or generic drugs. The acquisition of pharmaceutical drugs can occur through prescription-based or over-the-counter channels, with distribution taking place through hospital pharmacies, retail pharmacies/drug stores, and other outlets.

The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical drugs market size has grown strongly in recent years. It will grow from $1747.07 billion in 2024 to $1864.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in healthcare awareness, increased prevalence of respiratory diseases, changes in lifestyles, increase in pharmaceutical research and development (R&D) expenditure, increasing aging population, increased number of surgical procedures, strong economic growth in emerging markets and increased number of approvals for hematology/oncology (cancer) drugs.

The pharmaceutical drugs market size is expected to see strong growth in the next few years. It will grow to $2384.53 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing government support, increase in healthcare access, increase in investments, rapid growth in elderly population, rise in healthcare expenditure and rising awareness on immunization and vaccination. Major trends in the forecast period include use of biomarkers for drug development, increased development of next generation biologics, increased focus on personalized medicine, investment in artificial intelligence (AI) for drugs discovery, combination drug therapy to treat respiratory diseases, partnerships with wearables companies to improve drug research and development, use of 3D printing technology in drug manufacturing, microneedle pills to improve and enhance drug delivery and development of vaccines using MRNA.

The increase in sedentary jobs, busy lifestyles, and evolving consumer preferences is impacting the global disease landscape, particularly the prevalence of non-communicable diseases such as cancer, diabetes, and cardiovascular conditions. Factors such as prolonged working hours, reduced physical activity, and unhealthy dietary habits contribute significantly to chronic diseases such as diabetes. According to the World Health Organization, noncommunicable diseases (NCDs) account for 41 million deaths annually, representing 74% of global mortality. This trend underscores the growing demand for biologic drugs to address conditions such as diabetes. These factors are anticipated to expand the global patient population, thereby fostering growth in the pharmaceutical drug market throughout the forecast period.

The rising incidence of rare diseases is anticipated to drive growth in the pharmaceutical drug market in the future. A rare disease is characterized by its low prevalence, affecting only a small number of individuals compared to more common health issues. Pharmaceutical drugs play a crucial role in better managing these diseases, identifying potential therapeutics, and preventing unnecessary treatments that may have severe side effects, thus facilitating effective treatment. For example, in July 2023, the GOV.UK, a UK government department, reported that there are currently over 7,000 known rare diseases, with new ones continually being identified as research advances. Approximately 80% of these diseases have a recognized genetic basis, and it is estimated that 1 in 17 people will be affected by a rare disease at some point in their lives. Consequently, the increasing incidence of rare diseases is contributing to the growth of the pharmaceutical drug market.

Leading companies in the pharmaceutical drug market are introducing innovative medications such as Sohonos (palovarotene) capsules to establish a competitive advantage. Sohonos, a retinoid, is designed to reduce the volume of new heterotopic ossification in individuals with fibrodysplasia ossificans progressiva (FOP). For instance, in August 2023, Ipsen Biopharmaceuticals, Inc., a France-based biopharmaceutical company, unveiled Sohonos (palovarotene). This retinoid is indicated for minimizing the volume of new heterotopic ossification in adults and pediatric patients (8 years and older for females, 10 years and older for males) with FOP-a rare genetic disorder characterized by abnormal bone development in areas not typically containing bone, leading to limited movement, deformities, and severe disability.

Leading companies in the pharmaceutical drug market are launching innovative medications, such as generic cancer drugs, to enhance treatment affordability and accessibility. A generic cancer drug is defined as a medication that contains the same active ingredients, dosage, safety, strength, quality, and intended use as a brand-name cancer drug, but is usually offered at a lower price. For example, in August 2024, Lupin Limited, an India-based pharmaceutical company, introduced Doxorubicin Hydrochloride Liposome Injection in the United States. This product is a generic equivalent of Baxter Healthcare's Doxil, which is used for treating ovarian cancer, AIDS-related Kaposi's Sarcoma, and multiple myeloma. The medication is available in single-dose vials of 20 mg/10 mL and 50 mg/25 mL. This launch comes after receiving FDA approval through Lupin's alliance partner, ForDoz Pharma Corporation, and is part of Lupin's strategy to expand its oncology portfolio.

Major companies operating in the pharmaceutical drugs market include Pfizer Inc., AbbVie, Johnson & Johnson, Merck & Co, Sanofi S.A., F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, AstraZeneca, GlaxosmithKline, Shanghai Pharmaceutical Drugs, Shanghai Fosun Pharmaceutical, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd. (Sinopharm), Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, Kalbe Farma, Hyphens Pharma, Adjuvanz Technology Pte Ltd., Alliance Pharm Pte Ltd., Teva UK Limited, Abbott Laboratories, Vectura Group, Boehringer Ingelheim, Mylan, Zentiva, Apotex, Gilead Sciences, Bayer, Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Ache, Mantecorp Farmasa, Libbs, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Julphar, Neopharma, Eurolab, Aspen Pharmacare Holdings Limited

North America was the largest region in the pharmaceutical drugs market in 2024. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical drugs market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Others
  • 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels
  • 3) By Drug Classification: Branded Drugs, Generic Drugs
  • 4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs, Prescription-Based Drugs
  • Subsegments:
  • 1) By Cardiovascular Drugs: Antihypertensives; Anticoagulants; Cholesterol-lowering agents
  • 2) By Dermatology Drugs: Topical Corticosteroids; Acne Treatments; Psoriasis Treatments
  • 3) By Gastrointestinal Drugs: Antacids; Proton Pump Inhibitors; Laxatives
  • 4) By Genito-Urinary Drugs: Hormonal Therapies; Anticholinergics for Overactive Bladder; Erectile Dysfunction Medications
  • 5) By Hematology Drugs: Anticoagulants; Blood Volume Expanders; Erythropoiesis Stimulating Agents
  • 6) By Anti-Infective Drugs: Antibiotics; Antivirals; Antifungals
  • 7) By Metabolic Disorder Drugs: Diabetes Medications; Obesity Management Drugs; Thyroid Hormone Replacement
  • 8) By Musculoskeletal Disorder Drugs: Non-steroidal Anti-inflammatory Drugs (NSAIDs); Disease-modifying Antirheumatic Drugs (DMARDs); Muscle Relaxants
  • 9) By Central Nervous System Drugs: Antidepressants; Antipsychotics; Anxiolytics
  • 10) By Others: Chemotherapeutics; Targeted Therapies; Immunotherapies; Glaucoma Treatments; Anti-allergy Drops; Retinal Disease Medications; Asthma Inhalers; COPD Medications; Antihistamines; Vaccines for Infectious Diseases; Therapeutic Nutrients for Chronic Conditions; Calcium Supplements; Iron Supplements; Magnesium Supplements
  • Companies Mentioned: Pfizer Inc.; AbbVie; Johnson & Johnson; Merck & Co; Sanofi S.A.
  • Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Drugs Market Characteristics

3. Pharmaceutical Drugs Market Trends And Strategies

4. Pharmaceutical Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pharmaceutical Drugs Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Drugs Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Drugs Total Addressable Market (TAM)

6. Pharmaceutical Drugs Market Segmentation

  • 6.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorder Drugs
  • Musculoskeletal Disorder Drugs
  • Central Nervous System Drugs
  • Others
  • 6.2. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Other Distribution Channels
  • 6.3. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 6.4. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Over-The-Counter (OTC) Drugs
  • Prescription-Based Drugs
  • 6.5. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Cardiovascular Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antihypertensives
  • Anticoagulants
  • Cholesterol-lowering Agents
  • 6.6. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Dermatology Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Corticosteroids
  • Acne Treatments
  • Psoriasis Treatments
  • 6.7. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Gastrointestinal Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antacids
  • Proton Pump Inhibitors
  • Laxatives
  • 6.8. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Genito-Urinary Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hormonal Therapies
  • Anticholinergics for Overactive Bladder
  • Erectile Dysfunction Medications
  • 6.9. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Hematology Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anticoagulants
  • Blood Volume Expanders
  • Erythropoiesis Stimulating Agents
  • 6.10. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Anti-Infective Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibiotics
  • Antivirals
  • Antifungals
  • 6.11. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Metabolic Disorder Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes Medications
  • Obesity Management Drugs
  • Thyroid Hormone Replacement
  • 6.12. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Musculoskeletal Disorder Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Disease-modifying Antirheumatic Drugs (DMARDs)
  • Muscle Relaxants
  • 6.13. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Central Nervous System Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antidepressants
  • Antipsychotics
  • Anxiolytics
  • 6.14. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemotherapeutics
  • Targeted Therapies
  • Immunotherapies
  • Glaucoma Treatments
  • Anti-allergy Drops
  • Retinal Disease Medications
  • Asthma Inhalers
  • COPD Medications
  • Antihistamines
  • Vaccines for Infectious Diseases
  • Therapeutic Nutrients for Chronic Conditions
  • Calcium Supplements
  • Iron Supplements
  • Magnesium Supplements

7. Pharmaceutical Drugs Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Drugs Market

  • 8.1. Asia-Pacific Pharmaceutical Drugs Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Drugs Market

  • 9.1. China Pharmaceutical Drugs Market Overview
  • 9.2. China Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Drugs Market

  • 10.1. India Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Drugs Market

  • 11.1. Japan Pharmaceutical Drugs Market Overview
  • 11.2. Japan Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Drugs Market

  • 12.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Drugs Market

  • 13.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Drugs Market

  • 14.1. South Korea Pharmaceutical Drugs Market Overview
  • 14.2. South Korea Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Bangladesh Pharmaceutical Drugs Market

  • 15.1. Bangladesh Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.2. Bangladesh Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Bangladesh Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. Thailand Pharmaceutical Drugs Market

  • 16.1. Thailand Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. Thailand Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. Thailand Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Vietnam Pharmaceutical Drugs Market

  • 17.1. Vietnam Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Vietnam Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Vietnam Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. Malaysia Pharmaceutical Drugs Market

  • 18.1. Malaysia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. Malaysia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. Malaysia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Singapore Pharmaceutical Drugs Market

  • 19.1. Singapore Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Singapore Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Singapore Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Philippines Pharmaceutical Drugs Market

  • 20.1. Philippines Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Philippines Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Philippines Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Hong Kong Pharmaceutical Drugs Market

  • 21.1. Hong Kong Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.2. Hong Kong Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Hong Kong Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. New Zealand Pharmaceutical Drugs Market

  • 22.1. New Zealand Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. New Zealand Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. New Zealand Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. Western Europe Pharmaceutical Drugs Market

  • 23.1. Western Europe Pharmaceutical Drugs Market Overview
  • 23.2. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. Western Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. Western Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. UK Pharmaceutical Drugs Market

  • 24.1. UK Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.2. UK Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. UK Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Germany Pharmaceutical Drugs Market

  • 25.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.2. Germany Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Germany Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. France Pharmaceutical Drugs Market

  • 26.1. France Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.2. France Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. France Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Italy Pharmaceutical Drugs Market

  • 27.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Italy Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Italy Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Spain Pharmaceutical Drugs Market

  • 28.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.2. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Spain Pharmaceutical Drugs Market

  • 29.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.2. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Austria Pharmaceutical Drugs Market

  • 30.1. Austria Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 30.2. Austria Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 30.3. Austria Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

31. Belgium Pharmaceutical Drugs Market

  • 31.1. Belgium Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 31.2. Belgium Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 31.3. Belgium Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

32. Denmark Pharmaceutical Drugs Market

  • 32.1. Denmark Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 32.2. Denmark Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 32.3. Denmark Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

33. Finland Pharmaceutical Drugs Market

  • 33.1. Finland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 33.2. Finland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 33.3. Finland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

34. Ireland Pharmaceutical Drugs Market

  • 34.1. Ireland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 34.2. Ireland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 34.3. Ireland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

35. Netherlands Pharmaceutical Drugs Market

  • 35.1. Netherlands Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 35.2. Netherlands Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 35.3. Netherlands Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

36. Norway Pharmaceutical Drugs Market

  • 36.1. Norway Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 36.2. Norway Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 36.3. Norway Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

37. Portugal Pharmaceutical Drugs Market

  • 37.1. Portugal Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 37.2. Portugal Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 37.3. Portugal Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

38. Sweden Pharmaceutical Drugs Market

  • 38.1. Sweden Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 38.2. Sweden Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 38.3. Sweden Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

39. Switzerland Pharmaceutical Drugs Market

  • 39.1. Switzerland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 39.2. Switzerland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 39.3. Switzerland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

40. Eastern Europe Pharmaceutical Drugs Market

  • 40.1. Eastern Europe Pharmaceutical Drugs Market Overview
  • 40.2. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 40.3. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 40.4. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

41. Russia Pharmaceutical Drugs Market

  • 41.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 41.2. Russia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 41.3. Russia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

42. Czech Republic Pharmaceutical Drugs Market

  • 42.1. Czech Republic Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 42.2. Czech Republic Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 42.3. Czech Republic Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

43. Poland Pharmaceutical Drugs Market

  • 43.1. Poland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 43.2. Poland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 43.3. Poland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

44. Romania Pharmaceutical Drugs Market

  • 44.1. Romania Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 44.2. Romania Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 44.3. Romania Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

45. Ukraine Pharmaceutical Drugs Market

  • 45.1. Ukraine Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 45.2. Ukraine Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 45.3. Ukraine Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

46. North America Pharmaceutical Drugs Market

  • 46.1. North America Pharmaceutical Drugs Market Overview
  • 46.2. North America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 46.3. North America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 46.4. North America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

47. USA Pharmaceutical Drugs Market

  • 47.1. USA Pharmaceutical Drugs Market Overview
  • 47.2. USA Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 47.3. USA Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 47.4. USA Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

48. Canada Pharmaceutical Drugs Market

  • 48.1. Canada Pharmaceutical Drugs Market Overview
  • 48.2. Canada Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 48.3. Canada Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 48.4. Canada Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.1. Mexico Pharmaceutical Drugs Market Overview
  • 49.2. Mexico Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.3. Mexico Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.4. Mexico Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

50. South America Pharmaceutical Drugs Market

  • 50.1. South America Pharmaceutical Drugs Market Overview
  • 50.2. South America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 50.3. South America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 50.4. South America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

51. Brazil Pharmaceutical Drugs Market

  • 51.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 51.2. Brazil Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 51.3. Brazil Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

52. Chile Pharmaceutical Drugs Market

  • 52.1. Chile Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 52.2. Chile Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 52.3. Chile Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

53. Argentina Pharmaceutical Drugs Market

  • 53.1. Argentina Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 53.2. Argentina Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 53.3. Argentina Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

54. Colombia Pharmaceutical Drugs Market

  • 54.1. Colombia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 54.2. Colombia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 54.3. Colombia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

55. Peru Pharmaceutical Drugs Market

  • 55.1. Peru Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 55.2. Peru Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 55.3. Peru Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

56. Middle East Pharmaceutical Drugs Market

  • 56.1. Middle East Pharmaceutical Drugs Market Overview
  • 56.2. Middle East Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 56.3. Middle East Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 56.4. Middle East Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

57. Saudi Arabia Pharmaceutical Drugs Market

  • 57.1. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 57.2. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 57.3. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

58. Israel Pharmaceutical Drugs Market

  • 58.1. Israel Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 58.2. Israel Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 58.3. Israel Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

59. Iran Pharmaceutical Drugs Market

  • 59.1. Iran Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 59.2. Iran Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 59.3. Iran Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

60. Turkey Pharmaceutical Drugs Market

  • 60.1. Turkey Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 60.2. Turkey Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 60.3. Turkey Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

61. United Arab Emirates Pharmaceutical Drugs Market

  • 61.1. United Arab Emirates Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 61.2. United Arab Emirates Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 61.3. United Arab Emirates Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

62. Africa Pharmaceutical Drugs Market

  • 62.1. Africa Pharmaceutical Drugs Market Overview
  • 62.2. Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 62.3. Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 62.4. Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

63. Egypt Pharmaceutical Drugs Market

  • 63.1. Egypt Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 63.2. Egypt Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 63.3. Egypt Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

64. Nigeria Pharmaceutical Drugs Market

  • 64.1. Nigeria Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 64.2. Nigeria Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 64.3. Nigeria Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

65. South Africa Pharmaceutical Drugs Market

  • 65.1. South Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 65.2. South Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 65.3. South Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

66. Pharmaceutical Drugs Market Competitive Landscape And Company Profiles

  • 66.1. Pharmaceutical Drugs Market Competitive Landscape
  • 66.2. Pharmaceutical Drugs Market Company Profiles
    • 66.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.4. Merck & Co Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

67. Pharmaceutical Drugs Market Other Major And Innovative Companies

  • 67.1. F. Hoffmann-La Roche Ltd.
  • 67.2. Novartis AG
  • 67.3. Bristol-Myers Squibb
  • 67.4. AstraZeneca
  • 67.5. GlaxosmithKline
  • 67.6. Shanghai Pharmaceutical Drugs
  • 67.7. Shanghai Fosun Pharmaceutical
  • 67.8. Takeda Pharmaceutical Company Ltd.
  • 67.9. Otsuka Pharmaceutical Co. Ltd.
  • 67.10. Daiichi Sankyo
  • 67.11. China National Pharmaceutical Group Co., Ltd. (Sinopharm)
  • 67.12. Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • 67.13. Jiangsu Hengrui Medicine Co., Ltd
  • 67.14. Hanmi Pharmaceutical
  • 67.15. Cipla Limited

68. Global Pharmaceutical Drugs Market Competitive Benchmarking And Dashboard

69. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

70. Recent Developments In The Pharmaceutical Drugs Market

71. Pharmaceutical Drugs Market High Potential Countries, Segments and Strategies

  • 71.1 Pharmaceutical Drugs Market In 2029 - Countries Offering Most New Opportunities
  • 71.2 Pharmaceutical Drugs Market In 2029 - Segments Offering Most New Opportunities
  • 71.3 Pharmaceutical Drugs Market In 2029 - Growth Strategies
    • 71.3.1 Market Trend Based Strategies
    • 71.3.2 Competitor Strategies

72. Appendix

  • 72.1. Abbreviations
  • 72.2. Currencies
  • 72.3. Historic And Forecast Inflation Rates
  • 72.4. Research Inquiries
  • 72.5. The Business Research Company
  • 72.6. Copyright And Disclaimer